Surgical Pain Control With Ropivacaine by Atomized Delivery

Completed · Phase 4 · Has a placebo group

Conditions studied: Pain

In brief

The purpose of this trial is to determine the effect of spraying a local anesthetic called Ropivacaine (numbing medicine) into the abdominal cavity prior to surgery. Ropivacaine is a local anesthetic used to block pain in the body. There are studies showing that Ropivacaine decreases the pain of surgery with minimally invasive (laparoscopic) appendix and gallbladder removal but has not been tried in robotic pelvic surgery.

Key facts

Study ID

NCT01480089

Run by

Loyola University

People needed

56

Starts

2011-11-01

Expected to finish

2013-02-01

Last updated by the study team

2016-07-27

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Consent to undergo robotic assisted gynecologic or urologic surgery
• Between the ages of 18 and 75
• Able to consent, fill out study documents, and complete all study procedures and follow-up visits

You may not qualify if…

• Patients with an allergy to local anesthetics
• Patients with severe underlying cardiovascular, renal or hepatic disease
• Pregnant patients

Where it is running

• Loyola University Medical Center — Maywood, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.